bioMérieux S.A. (BMXMF)
USD 103.09
(0.0%)
USD 103.09
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 439 Million EUR | -25.22% |
| 2022 | 587.2 Million EUR | -25.13% |
| 2021 | 784.3 Million EUR | 31.79% |
| 2020 | 595.1 Million EUR | 60.53% |
| 2019 | 370.7 Million EUR | 7.89% |
| 2018 | 343.6 Million EUR | 9.11% |
| 2017 | 314.9 Million EUR | 11.47% |
| 2016 | 282.5 Million EUR | 44.95% |
| 2015 | 194.9 Million EUR | -4.27% |
| 2014 | 203.6 Million EUR | -20.93% |
| 2013 | 257.5 Million EUR | 9.57% |
| 2012 | 235 Million EUR | -4.24% |
| 2011 | 245.4 Million EUR | 0.57% |
| 2010 | 244 Million EUR | 19.78% |
| 2009 | 203.7 Million EUR | 9.46% |
| 2008 | 186.1 Million EUR | 24.15% |
| 2007 | 149.9 Million EUR | -1.7% |
| 2006 | 152.5 Million EUR | 9.79% |
| 2005 | 138.9 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 288.3 Million EUR | 31.58% |
| 2023 Q4 | 219.1 Million EUR | 17.17% |
| 2023 FY | 439.1 Million EUR | -25.22% |
| 2023 Q2 | 187 Million EUR | -29.51% |
| 2022 FY | 587.2 Million EUR | -25.13% |
| 2022 Q2 | 265.5 Million EUR | -32.61% |
| 2022 Q4 | 265.3 Million EUR | -0.08% |
| 2021 Q4 | 394 Million EUR | 14.0% |
| 2021 FY | 784.3 Million EUR | 31.79% |
| 2021 Q2 | 345.6 Million EUR | 5.85% |
| 2020 Q4 | 326.5 Million EUR | 45.3% |
| 2020 FY | 595.1 Million EUR | 60.53% |
| 2020 Q2 | 224.7 Million EUR | 41.95% |
| 2019 Q2 | 172.6 Million EUR | -2.98% |
| 2019 Q4 | 158.3 Million EUR | -8.29% |
| 2019 FY | 370.7 Million EUR | 7.89% |
| 2018 Q2 | 185.6 Million EUR | 14.36% |
| 2018 FY | 343.6 Million EUR | 9.11% |
| 2018 Q4 | 177.9 Million EUR | -4.15% |
| 2017 Q4 | 162.3 Million EUR | -5.86% |
| 2017 FY | 314.9 Million EUR | 11.47% |
| 2017 Q2 | 172.4 Million EUR | 16.17% |
| 2016 Q4 | 148.4 Million EUR | -0.67% |
| 2016 FY | 282.5 Million EUR | 44.95% |
| 2016 Q2 | 149.4 Million EUR | 8.34% |
| 2015 FY | 194.9 Million EUR | -4.27% |
| 2015 Q4 | 137.9 Million EUR | 12.94% |
| 2015 Q2 | 122.1 Million EUR | -10.22% |
| 2014 Q2 | 90.8 Million EUR | -33.92% |
| 2014 FY | 203.6 Million EUR | -20.93% |
| 2014 Q4 | 136 Million EUR | 49.78% |
| 2013 Q4 | 137.4 Million EUR | 9.92% |
| 2013 FY | 257.5 Million EUR | 9.57% |
| 2013 Q2 | 125 Million EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 FY | 235 Million EUR | -4.24% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 FY | 245.4 Million EUR | 0.57% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 FY | 244 Million EUR | 19.78% |
| 2010 Q4 | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2009 FY | 203.7 Million EUR | 9.46% |
| 2008 FY | 186.1 Million EUR | 24.15% |
| 2007 FY | 149.9 Million EUR | -1.7% |
| 2006 FY | 152.5 Million EUR | 9.79% |
| 2005 FY | 138.9 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | 35446.216% |
| Arrayit Corporation | -3.62 Million USD | 12218.642% |
| Atlantic International Corp. | -5.73 Million USD | 7758.078% |
| Biocept, Inc. | -31.98 Million USD | 1472.604% |
| Bioqual, Inc. | -19.63 Thousand USD | 2235561.86% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | 56954.827% |
| DermTech, Inc. | -103.73 Million USD | 523.177% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 82.348% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 2207.578% |
| iMD Companies, Inc. | -175.44 Thousand USD | 250319.441% |
| IDenta Corp. | -1499.00 USD | 29286290.794% |
| Interpace Biosciences, Inc. | 2.8 Million USD | -15556.205% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | -1134560.119% |
| InVitro International | -25.33 Thousand USD | 1732607.202% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 6263.999% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 755537.775% |
| Medical Imaging Corp. | -819.48 Thousand USD | 53670.557% |
| NovelStem International Corp. | -3.52 Million USD | 12551.078% |
| Optigenex Inc. | 1.39 Million USD | -31463.773% |
| PharmChem, Inc. | 973.14 Thousand USD | -45011.376% |
| Proteome Sciences plc | -1.62 Million USD | 27182.048% |
| Response Genetics, Inc | -21.37 Million USD | 2153.609% |
| Rennova Health, Inc. | -1.4 Million USD | 31245.045% |
| RushNet, Inc. | -684.7 Thousand USD | 64215.203% |
| ScreenPro Security Inc. | -2.59 Million USD | 17033.932% |
| Stella Diagnostics Inc. | -11.42 Million USD | 3941.795% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 5766.885% |
| Todos Medical Ltd. | -9.74 Million USD | 4603.488% |